[1]白云云,王世进,李　赟.血清人附睾蛋白4和糖类抗原125联合检测对子宫内膜癌淋巴结转移的诊断价值[J].新乡医学院学报,2021,38(8):725-729.[doi:10.7683/xxyxyxb.2021.08.005]
　BAI Yunyun,WANG Shijin,LI Yun.Diagnostic value of combined detection of serum human epididymal protein 4 and carbohydrate antigen 125 for lymph node metastasis in endometrial cancer[J].Journal of Xinxiang Medical University,2021,38(8):725-729.[doi:10.7683/xxyxyxb.2021.08.005]
点击复制

血清人附睾蛋白4和糖类抗原125联合检测对子宫内膜癌淋巴结转移的诊断价值
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
38
期数:
2021年8
页码:
725-729
栏目:
临床研究
出版日期:
2021-08-05

文章信息/Info

Title:
Diagnostic value of combined detection of serum human epididymal protein 4 and carbohydrate antigen 125 for lymph node metastasis in endometrial cancer
作者:
白云云1; 王世进1; 李　赟2
（1.新乡医学院第一附属医院妇科，河南　卫辉　453100；2.北京核工业医院肿瘤科，北京　100012）
Author(s):
BAI Yunyun1; WANG Shijin1; LI Yun2
(1.Department of Gynecology，the First Affiliated Hospital of Xinxiang Medical University，Weihui 453100，Henan Province，China2.Department of Oncology，Beijing Nuclear Industry Hospital，Beijing 100012，China)
关键词:
子宫内膜癌; 人附睾分泌蛋白4; 糖类抗原125; 淋巴结转移
Keywords:
endometrial cancerhuman epididymal protein 4carbohydrate antigen 125lymph node metastasis
分类号:
R737.33
DOI:
10.7683/xxyxyxb.2021.08.005
文献标志码:
A
摘要:
目的　探讨血清人附睾蛋白4（HE4）和糖类抗原125（CA125）联合检测诊断子宫内膜癌淋巴结转移的价值。方法　选择2018年1月1日至2020年1月1日新乡医学院第一附属医院妇科收治的行规范手术治疗的91例子宫内膜癌患者为观察对象，收集患者的年龄、绝经状态、体质量指数（BMI）、癌组织肌层浸润深度、淋巴结转移等临床资料；术前2~3 d非月经期抽取患者空腹静脉血5 mL，检测血清HE4、CA125水平；根据术后病理报告结果统计子宫内膜癌患者的肌层浸润深度、有无盆腹腔淋巴结转移，判定血清HE4、CA125水平单独及联合检测诊断子宫内膜癌淋巴结转移的灵敏度、特异度、阳性预测值、阴性预测值及受试者工作特征曲线下面积(AUC)。结果　91例患者中有淋巴结转移18例（19.78%），无淋巴结转移73例（80.22%）。血清HE4、CA125水平与子宫内膜癌患者的肌层浸润深度、淋巴结转移有关（P＜0.05），与患者的年龄、绝经状态、BMI无关（P＞0.05）。血清HE4诊断子宫内膜癌发生淋巴结转移的敏感度为83.33%，特异度为76.71%，阳性预测值为46.88%，阴性预测值为94.92%；CA125诊断子宫内膜癌发生淋巴结转移的敏感度为55.56%，特异度为65.75%，阳性预测值为28.57%，阴性预测值为85.71%；血清HE4和CA125联合检测诊断子宫内膜癌发生淋巴结转移的敏感度为94.44%，特异度为93.15%，阳性预测值为73.91%，阴性预测值为98.55%；血清HE4、血清CA125单项及联合检测诊断子宫内膜癌发生淋巴结转移的敏感度、特异度、阳性预测值、阴性预测值比较差异有统计学意义（χ2=7.712、14.857、11.465、7.853，P＜0.05）；血清HE4与CA125单项检测诊断子宫内膜癌发生淋巴结转移的敏感度、特异度、阳性预测值、阴性预测值比较差异无统计学意义（χ2=3.273、2.139、2.394、2.812，P＞0.05）；血清HE4诊断子宫内膜癌发生淋巴结转移的敏感度、阴性预测值与血清HE4和CA125联合检测比较差异无统计学意义（P＞0.05），血清HE4诊断子宫内膜癌发生淋巴结转移的特异度、阳性预测值显著均低于血清HE4和CA125联合检测（P＜0.05）；血清CA125诊断子宫内膜癌发生淋巴结转移的敏感度、特异度、阳性预测值、阴性预测值均低于血清HE4和CA125联合检测（P＜0.05 ）；血清HE4、CA12单独及联合检测诊断子宫内膜癌发生淋巴结转移的AUC分别为0.878［95%置信区间（CI）：0.807~0.948］、0.899（95%CI：0.816~0.982）和0.966( 95%CI：0.929~1.000)，血清CA125单项检测诊断子宫内膜癌发生淋巴结转移的AUC高于血清HE4（P＜0.05），血清HE4和CA125联合检测诊断子宫内膜癌患者发生淋巴结转移的AUC高于血清HE4、CA125单项检测（P＜0.05）。结论　血清HE4和CA125可作为诊断子宫内膜癌发生淋巴结转移的肿瘤标志物，联合检测HE4和C125对诊断子宫内膜癌发生淋巴结转移具有较高的价值。
Abstract:
Objective　To explore the value of combined detection of serum human epididymal protein 4 (HE4) and carbohydrate antigen 125 (CA125) in the diagnosis of lymph node metastasis in endometrial cancer.Methods　A total of 91 patients with endometrial cancer who underwent standardized surgical treatment in the Department of Gynecology of the First Affiliated Hospital of Xinxiang Medical University from January 1,2018 to January 1,2020 were selected as observation objects.The age，menopausal status，body mass index (BMI)，the depth of cancer tissue muscle layer invasion，lymph node metastasis and other clinical data of the patients were collected.Five milliliter of fasting venous blood of patients in non-menstrual period before 2-3 days of operation was taken,and the levels of serum HE4 and CA125 were detected.According to the results of the postoperative pathology report，the depth of myometrial invasion and the presence or absence of pelvic and abdominal lymph node metastasis of patients with endometrial cancer were counted.The sensitivity，specificity，positive predictive value，negative predictive value and area under curve (AUC) of receiver operating characteristic of the serum HE4 and CA125 levels alone and in combination detection to diagnose lymph node metastasiss of endometrial cancer were determined.Results　Among the 91 patients,18 cases (19.78%) had lymph node metastasis，73 cases (80.22%) had no lymph node metastasis.Serum HE4 and CA125 levels were related to the depth of myometrial invasion and lymph node metastasis of patients with endometrial cancer (P<0.05)，but had no relation to the age，menopausal status and BMI of patients (P>0.05).The sensitivity of serum HE4 in diagnosing lymph node metastasis of endometrial cancer was 83.33%，the specificity was 76.71%，the positive predictive value was 46.88%，and the negative predictive value was 94.92%the sensitivity of CA125 in diagnosing lymph node metastasis of endometrial cancer was 55.56%，the specificity was 65.75%，the positive predictive value was 28.57%，and the negative predictive value was 85.71%the sensitivity of combined detection of serum HE4 and CA125 in the diagnosis of lymphnode metastasis of endometrial cancer was 94.44%，the specificity was 93.15%，the positive predictive value was 73.91%，and the negative predictive value was 98.55%.There were significant differences in the sensitivity,specificity,positive predictive value and negative predictive value of combined detection of serum HE4 and CA125,single detection of serum HE4,and single detection of serum CA125 for the diagnosis of lymph node metastasis of endometrial cancer (χ2= 7.712,14.857,11.465,7.853P＜0.05)among them,there were no significant differences in the sensitivity,specificity,positive predictive value and negative predictive value between the single detection of serum HE4 and single detection of serum CA125 in the diagnosis of lymph node metastasis of endometrial cancer (χ2=3.273,2.139,2.394,2.812P>0.05)the sensitivity and negative predictive value of serum HE4 in the diagnosis of lymph node metastasis of endometrial cancer were not statistically different from those of combined detection of serum HE4 and CA125 (P>0.05)the specificity and positive predictive value of single detection of serum HE4 in the diagnosis of lymph node metastasis of endometrial cancer were significantly lower than those of the combined detection of serum HE4 and CA125 (P＜0.05)the sensitivity,specificity,positive predictive value and negative predictive value of single detection of serum CA125 in the diagnosis of lymph node metastasis of endometrial cancer were significantly lower than those of the combined detection of serum HE4 and CA125 (P<0.05 ).The AUC of serum HE4 and CA125 in alone and combination for diagnosis of lymph node metastasis of endometrial cancer were 0.878 ［95% confidence interval(CI):0.807-0.948］，0.899 (95% CI:0.816-0.982) and 0.966 (95% CI:0.929-1.000)，respectivelythe AUC of single detection of serum CA125 in the diagnosis of lymph node metastasis of endometrial cancer was significantly higher than that of serum HE4 (P<0.05)，and the AUC of combined detection of serum HE4 and CA125 in the diagnosis of lymph node metastasis of endometrial cancer was significantly higher than that of single detection of serum HE4 and CA125 (P<0.05). Conclusion　Serum HE4 and CA125 can be used as tumor markers for the diagnosis of lymph node metastasis of endometrial cancer，and the combined detection of HE4 and C125 has high value in the diagnosis of lymph node metastasis of endometrial cancer.

参考文献/References:

［1］　赵健,高坚荣.检测CA199、VEGF、HE4预测子宫内膜癌淋巴结转移价值［J］.中国计划生育学杂志,2020,28(11):1901-1904,1908.
［2］　季瑞,陆云燕.子宫内膜癌临床病理特征与盆腹腔淋巴结转移的相关性分析［J］.现代肿瘤医学,2019,27(19):3491-3494.
［3］　张瑜,张静,王乐,等.血清人附睾蛋白4及糖类抗原125对判断子宫内膜癌淋巴结转移的临床意义［J］.实用医学杂志,2020,36(10):1340-1343,1348.
［4］　琚莹,杨君.MicroRNA-182和Ki-67在Ⅰ型和Ⅱ型子宫内膜癌组织中的表达［J］.新乡医学院学报,2020,37(1):57-62.
［5］　黎阳成,朱雪莲,贺志军.子宫内膜癌患者HE4,CA125水平变化及其临床意义［J］.检验医学与临床,2019,16(4):48-51,55.
［6］　赵昌芹,张瑞林,廖丽川.早期子宫内膜癌淋巴脉管间隙浸润与盆腔淋巴结转移的关系及其预后价值［J］.癌症进展,2019,17(18):2176-2179.
［7］　包媛媛,洛若愚.血清CA125,HE4联合ROMA指数在早期卵巢癌及卵巢子宫内膜异位囊肿中的鉴别诊断价值［J］.中国性科学,2019,28(12):29-32.
［8］　白朝怡,王颖梅,滕飞,等.血清人附睾分泌蛋白E4及CA125联合检测对子宫内膜癌淋巴结转移的预测价值［J］.中华妇产科杂志,2014,49(7):543-546.
［9］　孙润蛟,金仙玉,刘桂香,等.人附睾分泌蛋白4在子宫内膜癌组织中的表达及临床意义［J］.中国医学创新,2016，13（30):1-7.
［10］　郭建宾,钱海利,马飞,等.子宫内膜癌患者再发乳腺癌的临床病理特征及预后分析［J］.解放军医学杂志,2020,45(1):100-104.
［11］　陈红.血浆溶血磷脂酸及CA125与子宫内膜癌临床病理特征之间的关系分析［J］.中国医药科学,2017,7(22):47-50.
［12］　寇建芳,孟跃进.宫腔镜检查联合血清人附睾分泌蛋白及糖类抗原和miR-21早期诊断子宫内膜癌的临床价值［J］.新乡医学院学报,2019,36(2):185-189.
［13］　NSAL M，KIMYON C G，KARALOK A，et al.The preoperative serum CA125 can predict the lymph node metastasis in endo-metrioidtype endometrial cancer［J］.Ginekol Pol，2018，89（11）：599-606.
［14］　WANG Y,HAN C,TENG F,et al.Predictive value of serum HE4 and CA125 concentrations for lymphatic metastasis of endometrial cancer［J］.Int J Gynaecol Obstet,2017,136(1):58-63.
［15］　李文燕,李瑞萍,郭钰珍.子宫内膜癌患者术前血清胰岛素水平与淋巴结转移关系的前瞻性队列研究［J］.中国妇幼保健，2019,34（17）：4053-4058.
［16］　陈红敏,高玲,罗艳林,等.联合分子标志物检测在预测子宫内膜癌淋巴结转移中的应用［J］.肿瘤学杂志,2017,23(11):1000-1003.
［17］　LAN T,MU C,WANG Z,et al.Diagnostic and prognostic values of serum EpCAM,TGM2,and HE4 levels in endometrial cancer［J］.Fron Oncol,2020,10:1697.
［18］　MOLONEY K,JANDA M,FRUMOVITZ M,et al.Development of a surgical competency assessment tool for sentinel lymph node dissection by minimally invasive surgery for endometrial cancer［J］.Int J Gynecol Cancer,2021,31(5):647-655.
［19］　刘丹萍,曾友玲,梅凡.子宫内膜癌淋巴结转移的危险因素及预后分析［J］.癌症进展,2019,17(3):106-108.
［20］　LI Y,CONG P,WANG P,et al.Risk factors for pelvic lymph node metastasis in endometrial cancer［J］.Arch Gynecol Obstet,2019,300(4):1007-1013.
［21］　CYMBALUK-POSKA A,CHUDECKA-GAZ A,PIUS-SADOWSKA E,et al.The role of lipocalin-2 serum levels in the diagnostics of endometrial cancer［J］.Cancer Biomark,2019,24(3):315-324.
［22］　杨之敏,邱堃,王静,等.血浆溶血磷脂酸及CA125水平与子宫内膜癌临床病理特征的关系［J］.中国肿瘤临床与康复,2017,24(5):556-559.
［23］　LIU S Y,BILAL M A,ZHU J H,et al.Diagnostic value of serum human epididymis protein 4 in esophageal squamous cell carcinoma［J］.World J Gastrointest Oncol,2020,12(10):1167-1176.
［24］　KALOGERA E,HOUTEN H K V,SANGARALINGHAM L R,et al.Use of bowel preparation does not reduce postoperative infectious morbidity following minimally invasive or open hysterectomies［J］.Am J Obstet Gynecol,2020,223(2):231.
［25］　BIGNOTTI E,RAGNOLI M,ZANOTTI L,et al.Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients［J］.Br J Cancer,2011,104(9):1418-1425.
［26］　MOORE R G,BROWN A K,MILLER M C,et al.Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus［J］.Gynecol Oncol,2008,110(2):196-201.
［27］　WANG Y,HAN C,TENG F,et al.Predictive value of serum HE4 and CA125 concentrations for lymphatic metastasis of endometrial cancer［J］.Int J Gynaecol Obstet,2017,136(1):58-63.

相似文献/References:

[1]陈彩霞,赵孟军,李国芸.子宫内膜癌160例临床和手术病理分期比较[J].新乡医学院学报,2005,22(06):582.
　CHEN Caixia,ZI-UkO Mengjun,LI Guoyun.Comparison of clinical stage and operative pathological stage in 1 60 patients with endometrial cancer[J].Journal of Xinxiang Medical University,2005,22(8):582.
[2]周开梅,袁森辅,吴　晶,等.人附睾蛋白4和糖类抗原125在子宫内膜癌组织中的表达[J].新乡医学院学报,2018,35(3):219.[doi:10.7683/xxyxyxb.2018.03.015]
　ZHOU Kai-mei,YUAN Sen-fu,WU Jing,et al.Expression of human epididymis protein 4 and carbohydrate antigen 125 in endometrial carcinoma tissues[J].Journal of Xinxiang Medical University,2018,35(8):219.[doi:10.7683/xxyxyxb.2018.03.015]
[3]琚　莹,杨　君.MicroRNA-182和Ki-67在Ⅰ型和Ⅱ型子宫内膜癌组织中的表达[J].新乡医学院学报,2020,37(1):057.[doi:10.7683/xxyxyxb.2020.01.014]
　JU Ying,YANG Jun.Expression of microRNA-182 and Ki-67 in type Ⅰ and type Ⅱ endometrial carcinoma tissues[J].Journal of Xinxiang Medical University,2020,37(8):057.[doi:10.7683/xxyxyxb.2020.01.014]
[4]赵彩琴,赵宝祥.新辅助放射治疗和化学治疗联合手术治疗晚期子宫内膜癌效果观察[J].新乡医学院学报,2019,36(1):074.[doi:10.7683/xxyxyxb.2019.01.016]
　ZHAO Cai-qin,ZHAO Bao-xiang.Effect of neoadjuvant radiotherapy and chemotherapy combined with surgery in the treatment of advanced endometrial carcinoma[J].Journal of Xinxiang Medical University,2019,36(8):074.[doi:10.7683/xxyxyxb.2019.01.016]
[5]豆秋彦,冯　文,李春霖.脂肪因子chemerin在女性常见恶性肿瘤中的作用研究进展[J].新乡医学院学报,2020,37(12):1195.[doi:10.7683/xxyxyxb.2020.12.021]
[6]寇建芳,孟跃进.宫腔镜检查联合血清人附睾分泌蛋白及糖类抗原和miR-21早期诊断子宫内膜癌的临床价值[J].新乡医学院学报,2019,36(2):185.[doi:10.7683/xxyxyxb.2019.02.022]
　KOU Jian-fang,MENG Yue-jin.Clinical value of hysteroscopy combined with serum human epididymis protein 4,carbohydrate antigen 125 and miR-21 in early diagnosis of endometrial carcinoma[J].Journal of Xinxiang Medical University,2019,36(8):185.[doi:10.7683/xxyxyxb.2019.02.022]
[7]张　英,马瑞霞,杜艳云,等.MicroRNA-15b在子宫内膜癌组织中的表达及其对子宫内膜癌细胞增殖的影响[J].新乡医学院学报,2018,35(3):177.[doi:10.7683/xxyxyxb.2018.03.004]
　ZHANG Ying,MA Rui-xia,DU Yan-yun,et al.Expression of microRNA-15b in endometrial carcinoma and its effect on proliferation of endometrial carcinoma cells[J].Journal of Xinxiang Medical University,2018,35(8):177.[doi:10.7683/xxyxyxb.2018.03.004]
[8]郭会敏,范毛川,华方方,等.脂联素对子宫内膜癌Ishikawa细胞增殖及侵袭和转移能力的影响[J].新乡医学院学报,2018,35(7):563.[doi:10.7683/xxyxyxb.2018.07.004]
　GUO Hui-min,FAN Mao-chuan,HUA Fang-fang,et al.Effects of adiponectin on invasion and metastasis of endometrial carcinoma Ishikawa cells[J].Journal of Xinxiang Medical University,2018,35(8):563.[doi:10.7683/xxyxyxb.2018.07.004]
[9]徐　岚.大蒜素促进人子宫内膜癌细胞株HEC-1细胞凋亡的细胞外信号调节激酶信号通路研究[J].新乡医学院学报,2016,33(1):020.[doi:10.7683/xxyxyxb.2016.01.006]
　XU Lan.Study on the extracellular signal-regulated kinase signal pathway of allicin promoting apoptosis in human endometrial cancer HEC-1 cell strain[J].Journal of Xinxiang Medical University,2016,33(8):020.[doi:10.7683/xxyxyxb.2016.01.006]
[10]朱春霞,孟　勇,王秀虹.血清人附睾分泌蛋白4、糖类抗原125和脂联素在子宫内膜癌淋巴结转移诊断中的价值[J].新乡医学院学报,2016,33(5):403.[doi:10.7683/xxyxyxb.2016.05.016]
　ZHU Chun-xia,MENG Yong,WANG Xiu-hong.Value of serum human epididymis protein 4，carbohydrate antigen 125 and adiponectin in the diagnosis of lymphatic metastasis in patients with endometrial carcinoma[J].Journal of Xinxiang Medical University,2016,33(8):403.[doi:10.7683/xxyxyxb.2016.05.016]

更新日期/Last Update: 2021-08-05